Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Kato

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
Scientific Reports|October 1, 2021
First results of undersea muography with the Tokyo-Bay Seafloor Hyper-Kilometric Submarine Deep DetectorHiroyuki K M Tanaka, Masaatsu Aichi, Cristiano Bozza, et al.
Scientific Reports|February 24, 2017
Classification of idiopathic interstitial pneumonias using anti-myxovirus resistance-protein 1 autoantibodyYoshimasa Hamano, Hiroshi Kida, Shoichi Ihara, et al.
The Journal of Experimental Medicine|October 14, 2021
Identification of conserved SARS-CoV-2 spike epitopes that expand public cTfh clonotypes in mild COVID-19 patientsXiuyuan Lu, Yuki Hosono, Masamichi Nagae, et al.
Therapeutic Advances in Medical Oncology|June 16, 2023
Prospective exosome-focused translational research for afatinib (EXTRA) study of patients with nonsmall cell lung cancer harboring <i>EGFR</i> mutation: an observational clinical studySaori Takata, Kei Morikawa, Hisashi Tanaka, et al.
Scientific Reports|February 11, 2026
Efficacy and safety findings of the EXTRA study in older adult EGFR-mutant lung cancer patients receiving afatinib as first-line treatmentKei Morikawa, Saori Takata, Hisashi Tanaka, et al.
Scientific Reports|April 13, 2022
Periodic sea-level oscillation in Tokyo Bay detected with the Tokyo-Bay seafloor hyper-kilometric submarine deep detector (TS-HKMSDD)Hiroyuki K M Tanaka, Masaatsu Aichi, Szabolcs József Balogh, et al.
JCI Insight|February 8, 2024
Sema6D forward signaling impairs T cell activation and proliferation in head and neck cancerTakashi Hirai, Yujiro Naito, Shohei Koyama, et al.
Life Science Alliance|September 17, 2024
Clonal landscape of autoantibody-secreting plasmablasts in COVID-19 patientsShuhei Sakakibara, Yu-Chen Liu, Masakazu Ishikawa, et al.
Nature Communications|June 17, 2025
Single-cell analysis reveals immune cell abnormalities underlying the clinical heterogeneity of patients with systemic sclerosisHiroshi Shimagami, Kei Nishimura, Hiroaki Matsushita, et al.
JCI Insight|December 21, 2018
Semaphorin 7A promotes EGFR-TKI resistance in EGFR mutant lung adenocarcinoma cellsYuhei Kinehara, Izumi Nagatomo, Shohei Koyama, et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Scientific Reports|October 1, 2021
First results of undersea muography with the Tokyo-Bay Seafloor Hyper-Kilometric Submarine Deep DetectorHiroyuki K M Tanaka, Masaatsu Aichi, Cristiano Bozza, et al.
Scientific Reports|February 24, 2017
Classification of idiopathic interstitial pneumonias using anti-myxovirus resistance-protein 1 autoantibodyYoshimasa Hamano, Hiroshi Kida, Shoichi Ihara, et al.
The Journal of Experimental Medicine|October 14, 2021
Identification of conserved SARS-CoV-2 spike epitopes that expand public cTfh clonotypes in mild COVID-19 patientsXiuyuan Lu, Yuki Hosono, Masamichi Nagae, et al.
Therapeutic Advances in Medical Oncology|June 16, 2023
Prospective exosome-focused translational research for afatinib (EXTRA) study of patients with nonsmall cell lung cancer harboring <i>EGFR</i> mutation: an observational clinical studySaori Takata, Kei Morikawa, Hisashi Tanaka, et al.
Scientific Reports|February 11, 2026
Efficacy and safety findings of the EXTRA study in older adult EGFR-mutant lung cancer patients receiving afatinib as first-line treatmentKei Morikawa, Saori Takata, Hisashi Tanaka, et al.
Scientific Reports|April 13, 2022
Periodic sea-level oscillation in Tokyo Bay detected with the Tokyo-Bay seafloor hyper-kilometric submarine deep detector (TS-HKMSDD)Hiroyuki K M Tanaka, Masaatsu Aichi, Szabolcs József Balogh, et al.
JCI Insight|February 8, 2024
Sema6D forward signaling impairs T cell activation and proliferation in head and neck cancerTakashi Hirai, Yujiro Naito, Shohei Koyama, et al.
Life Science Alliance|September 17, 2024
Clonal landscape of autoantibody-secreting plasmablasts in COVID-19 patientsShuhei Sakakibara, Yu-Chen Liu, Masakazu Ishikawa, et al.
Nature Communications|June 17, 2025
Single-cell analysis reveals immune cell abnormalities underlying the clinical heterogeneity of patients with systemic sclerosisHiroshi Shimagami, Kei Nishimura, Hiroaki Matsushita, et al.
JCI Insight|December 21, 2018
Semaphorin 7A promotes EGFR-TKI resistance in EGFR mutant lung adenocarcinoma cellsYuhei Kinehara, Izumi Nagatomo, Shohei Koyama, et al.
Pageof 12